JBT Marel Reports Strong FY2025 Results, Exceeds $1B Quarterly Revenue, and Issues Robust 2026 Guidance
JBTM sits 81% above its 52-week low of $90.08.
Summary
JBT Marel Corporation announced strong fourth quarter and full year 2025 financial results, including record quarterly revenue and orders, successful synergy realization post-acquisition, and provided robust 2026 guidance with significant adjusted EPS growth.
Key Events · Earnings and Guidance · JBTM
-
Strong Full Year 2025 Performance
Reported $3.8 billion in revenue and $600 million in Adjusted EBITDA for fiscal year 2025, with record quarterly orders and revenue exceeding $1.0 billion.
-
Successful Integration & Synergies
Realized $43 million in year-over-year synergy savings in 2025, achieving an annualized run rate of $85 million, and anticipates $60 million more in 2026.
-
Balance Sheet De-leveraging
Reduced net debt to trailing twelve months adjusted EBITDA to 2.9x, de-leveraging by approximately 1.1x since the close of the Marel transaction.
-
Robust 2026 Guidance
Forecasts full year 2026 revenue of $3.99 billion to $4.065 billion and adjusted EPS of $8.00 to $8.50, representing significant year-over-year growth.
Analysis · JBTM · Technology
The filing highlights JBT Marel's successful integration of the Marel acquisition, evidenced by significant synergy savings and a substantial reduction in leverage. The company's ability to achieve record quarterly revenue and orders, coupled with strong adjusted EBITDA and a positive outlook for 2026, suggests effective operational execution and a favorable market position. The GAAP loss is primarily due to non-recurring acquisition-related costs, which are excluded from the more indicative adjusted figures. The robust 2026 guidance, particularly the projected 25-30% growth in adjusted EPS, indicates strong future performance and could further support investor confidence, especially as the stock trades near its 52-week high.
At the time of this filing, JBTM was trading at $163.40 on NYSE in the Technology sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $90.08 to $170.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.